Therapeutic observation of transcutaneous auricular vagus nerve stimulation for chronic migraine in pediatric patients: a case report
Authors:
Open Access
- 10 November 2025
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 6, 1686043
Abstract
Background: Although interest in migraine has increased in recent years, important gaps remain in understanding and optimizing its management. These gaps are particularly pronounced in pediatric migraine, which continues to be understudied. Case report: This case report demonstrates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in an 8-year-old male patient with refractory chronic migraine with aura [two to three weekly episodes; visual analog scale (VAS): 5–9; duration of each episode was 24 h]. After discontinuing all prophylactic and abortive medications (except ibuprofen suspensions such as Motrin®), the patient underwent a 28-week taVNS protocol that involved the following phases: a 4-week acute intervention, a 4-week intermission period, a 12-week preventive intervention, and an 8-week follow-up. During the acute intervention phase, the patient’s headache duration decreased by 84.4%, and frequency was reduced to fewer than two episodes/week, with complete aura resolution. The preventive intervention yielded further improvement to fewer than 1 episode/week by week 8 (with a 37.5% reduction in medication use). At final follow-up, the patient maintained a medication-free status with only three mild episodes (VAS: 1–3; duration <30 min) in the last 4 weeks. No adverse events were observed. Conclusion: taVNS was effective and safe in the management of chronic migraine in the reported pediatric patient. These findings suggest the need for further evaluation of this non-pharmacological intervention in pediatric migraine.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2024A1515013109)
This publication has 33 references indexed in Scilit:
- Combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing enhances insomnia treatment efficacy: A pilot studyBrain Stimulation, 2023
- Altered functional brain network patterns in patients with migraine without aura after transcutaneous auricular vagus nerve stimulationScientific Reports, 2023
- Evaluation of the Modulation Effects Evoked by Different Transcutaneous Auricular Vagus Nerve Stimulation Frequencies Along the Central Vagus Nerve Pathway in Migraine: A Functional Magnetic Resonance Imaging StudyNeuromodulation: Technology at the Neural Interface, 2022
- The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trialBrain Stimulation, 2022
- Human intracranial recordings reveal distinct cortical activity patterns during invasive and non-invasive vagus nerve stimulationScientific Reports, 2021
- Epidemiology of Headache in Children and Adolescents—Another Type of PandemiaCurrent Pain and Headache Reports, 2020
- Stimulus frequency modulates brainstem response to respiratory-gated transcutaneous auricular vagus nerve stimulationBrain Stimulation, 2020
- The influence of respiration on brainstem and cardiovagal response to auricular vagus nerve stimulation: A multimodal ultrahigh-field (7T) fMRI studyBrain Stimulation, 2019
- Evaluation of cognitive functions in migraineurs treated with topiramateJournal of Clinical Neuroscience, 2019
- Interoception, homeostatic emotions and sympathovagal balancePhilosophical Transactions of the Royal Society B: Biological Sciences, 2016